I-Melasma ingenye yezinkinga ze-pigment ezikhungathekisa kakhulu eziphathwa imitholampilo. Ibuya ngemva kwe-laser, ivutha ilanga namahomoni, futhi ngokuvamile iyehluleka ukuphendula i-hydroquinone iyodwa. Kungakho umjovo we-tranexamic acid wokwenziwa mhlophe kwesikhumba kanye nokulawula i-melasma ususukile endleleni ye-niche waya esicelweni esijwayelekile sezinqubo zobuhle kulo lonke elase-Asia, eMpumalanga Ephakathi naseYurophu. Lo mhlahlandlela uhlanganisa ukuthi i-tranexamic acid (TXA) isebenza kanjani kumbala, lokho okushiwo idatha yomtholampilo eshicilelwe, ukuthi odokotela bavame ukusebenzisa kanjani iphrothokholi ye-TXA mesotherapy, nokuthi yiziphi abasabalalisi nemikhiqizo yasemtholampilo okufanele bayihlole ngaphambi kokuthola ifomula ye-TXA.
Iyini I-Tranexamic Acid Futhi Kungani Isetshenziswa Esikhumbeni?
I-Tranexamic acid iphuma ku-amino acid i-lysine. Yaqala ukwakhiwa njengesidakamizwa se-antifibrinolytic, okusho ukuthi inciphisa ukopha ngokuvimbela ukuguqulwa kwe-plasminogen ku-plasmin. Odokotela besikhumba baba nesithakazelo kuyo ngemva kokuba abacwaningi bebone ukuthi ukuvimba indlela ye-plasminogen-plasmin nakho kunciphisa umbala owenziwe yi-ultraviolet.
Emithi yobuhle, i-TXA manje isisetshenziswa ngezindlela ezintathu eziyinhloko:
Ama-serum we-topical kanye nokhilimu, ngokuvamile ekugxilweni okuphansi
Amaphilisi omlomo , anqunywe odokotela nge-melasma eqinile
I-Intradermal microinjection (mesotherapy) , lapho isisombululo se-dilute sibekwe ngqo endaweni ene-pigmented
Lesi sihloko sigxile emzileni wesithathu, ovame ukuseshwa njengokuthi 'tranexamic acid mesotherapy' noma 'tranexamic acid ampoule yesikhumba'. Ukuze uthole umbono obanzi wezinketho zokukhanya ezijovayo, bheka umhlahlandlela wethu ku ukuthi imijovo ekhanyisa isikhumba isiza kanjani ekwelapheni i-hyperpigmentation.
I-Tranexamic Acid Yehlisa Kanjani Ukuba Nebala
I-Melasma ayiyona nje 'i-melanin eningi'. Kuhilela ingxoxo phakathi kwezinhlobo eziningana zamaseli esikhumbeni. Nansi inguqulo eyenziwe lula yokuthi i-TXA iyiphazamisa kanjani.
Ukuvimbela isignali ye-plasmin
Lapho isikhumba sivezwa ekukhanyeni kwe-UV, ama-keratinocyte akhiqiza i-activator ye-plasminogen eyengeziwe. I-Plasmin ibe isikhipha ama-molecule abonisa izimpawu njenge-arachidonic acid kanye ne-prostaglandin, asunduza ama-melanocyte ukuze akhiqize i-melanin eyengeziwe. I-TXA ivimba ukwenziwa kusebenze kwe-plasminogen, ukuze isignali evuselelayo ibe buthaka emthonjeni wayo.
Ukukhomba ingxenye ye-vascular
Izilonda ze-Melasma zivame ukukhombisa imithambo yegazi emincane kunesikhumba esizungezile, futhi izici zokukhula kwemithambo zibonakala zondla umjikelezo we-pigment. Ngenxa yokuthi i-TXA iphinde isebenze endleleni ye-plasmin ehilelekile ku-angiogenesis, ingasiza ngokubomvu-nsundu, ukubukeka kwemithambo kwamanye amabala e-melasma. Lesi esinye isizathu esenza ukuthi i-TXA iziphathe ngendlela ehlukile kuma-tyrosinase inhibitors.
Kungani lokhu kubalulekile ekukhetheni ukwelashwa
Izithako ezifana ne-glutathione, uvithamini C, i-kojic acid ne-arbutin ngokuvamile zisebenza ku-melanin synthesis ngokwayo. I-TXA isebenza phezulu, kumasiginali ayibangelayo. Lokho kuyenza ibe uzakwethu onengqondo esikhundleni sokungena esikhundleni. Uma ufuna imininingwane ngasohlangothini lwe-antioxidant, isihloko sethu sithi Imijovo ye-glutathione kanye ne-skin whitening ichaza ukuthi i-glutathione iyithonya kanjani i-pigment. Okunye kwalo mhlahlandlela kuhlala ne-TXA ne-melasma.
Okuboniswa Ubufakazi Bomtholampilo
I-TXA injection encane iye yacutshungulwa ezivivinyweni ezibuyekezwe ontanga, nakuba eziningi zincane futhi zinelebula evulekile. Izifundo ezimbili ezivame ukucashunwa zinikeza isithombe esingokoqobo:
U-Lee et al., Ukuhlinzwa Kwesikhumba (2006). Ocwaningweni lokuhlola oluvulekile lwamaviki ayi-12 kwabesifazane base-Korea abayi-100 abane-melasma, u-0.05 mL we-TXA (4 mg/mL) wajovwa nge-intradermally ngezikhathi ezingu-1 cm kanye ngesonto. Iziguli ezingamashumi ayisishiyagalombili nanhlanu ziqede ucwaningo. I-Melasma Area kanye ne-Severity Index (MASI) yehla kusukela ku-13.22 ekuqaleni kuya ku-7.57 ngesonto le-12, futhi imiphumela emibi yachazwa njengento encane.
Budamakuntla et al., Journal of Cutaneous and Aesthetic Surgery (2013). Iziguli ezingamashumi ayisithupha zafakwa ngokungahleliwe kuma-TXA microinjections noma i-TXA ilethwa nge-microneedling, namaseshini amathathu anyanga zonke. I-MASI ithuthuke ngo-35.72% eqenjini le-microinjection kanye nama-44.41% eqenjini le-microneedling, ngaphandle kwezenzakalo ezinkulu ezimbi ezibikiwe.
Okusikiselwa yilezi zifundo:
I-TXA mesotherapy ingaveza ukuncipha okunengqondo kobunzima be-melasma emasontweni ayi-8-12.
Imiphumela iyahlukahluka. Ocwaningweni luka-Lee, iziguli eziningi zilinganise ukuthuthuka kwazo njengokuthi 'kulungile' (26–50% ukukhanya) esikhundleni sokuvunyelwa okuphelele.
Indlela yokulethwa ibalulekile, futhi inhlanganisela ne-microneedling ingase ithuthukise ukungena.
Alukho ucwaningo olufakazela ukuvunyelwa unomphela. I-Melasma yisimo esingelapheki, ngakho imitholampilo kufanele yethule i-TXA njengethuluzi lokulawula nokunakekela, hhayi ikhambi.
Iphrothokholi Ejwayelekile ye-TXA Mesotherapy
Amaphrothokholi ayahluka phakathi kwabasebenzi nemikhiqizo, futhi noma yiluphi uhlelo lokwelapha kufanele lulandele imiyalelo yokusetshenziswa komkhiqizo kanye nemithetho yezokwelapha yendawo. Isakhiwo esijwayelekile esisetshenziswa emitholampilo sibukeka kanje.
Ukukhetha nokulungiselela isiguli
Qinisekisa ukuxilongwa. I-Melasma, i-post-inflammatory hyperpigmentation kanye nama-solar lentigines asabela ngendlela ehlukile.
Isikrini se-contraindication. I-TXA ithinta izindlela zokujiyisa, ngakho umlando we-thromboembolism, ukuphazamiseka kwamahlule, ukwelashwa kwe-anticoagulant noma ukukhulelwa kudinga ukubuyekezwa kodokotela ngaphambi kokwelashwa.
Thatha isithombe indawo ngaphansi kokukhanya okungaguquki, bese uyikora nge-MASI noma isikali esifanayo ukuze ulandele inhloso.
Hlanza isikhumba bese usebenzisa i-topical anesthetic uma kudingeka.
Indlela yokujova
Ukujula: ukubekwa kwe-intradermal okungaphezulu, cishe ku-0.5-1 mm.
Isikhala kanye nevolumu: ama-aliquots amancane asakazeka ngokulinganayo kuwo wonke isilonda. Amaphrothokholi ashicilelwe asetshenziswa cishe ngu-0.05 mL ngephuzu ngalinye ngezikhawu ezingu-1 cm.
Amathuluzi okulethwa: isipetu se-insulin, isibhamu esiyi-meso, noma ipeni le-microneedling nerola, kuye ngomklamo womkhiqizo nokuthandwa komtholampilo.
Imvamisa yeseshini
Izifundo ezishicilelwe zisetshenziswe izikhathi zamasonto onke (Lee 2006) noma izikhathi zanyanga zonke (Budamakuntla 2013). Izixazululo eziningi ze-mesotherapy ze-TXA zincoma iseshini eyodwa njalo emavikini amabili. Isifundo ngokuvamile siqhuba amaseshini angu-4-8, alandelwe ukwelashwa kokulungisa njengoba kudingeka.
Ukunakekelwa kwangemuva
Ukuvikela ilanga okuqinile kobubanzi obubanzi nsuku zonke. Ngaphandle kwakho, noma yikuphi ukuthuthukiswa kuzofiphala.
Gwema ukushisa, ama-saunas kanye nokusebenza okuqinile amahora angama-24-48.
Lindela ububomvu obumaphakathi, imihuzuko ekhomba noma amaqhubu amancane avame ukuhlala phakathi nosuku noma ezimbili.
Ukuhlanganisa i-TXA Neminye Imisebenzi Ekhanyayo
Indlela ye-TXA ekhuphuka nomfula ihambisana kahle nezithako ezisebenza ngokuqhubekayo emgudwini we-melanin. Amafomu esimanje ngokuvamile ahlanganisa i-TXA ne:
I-Glutathione ne-vitamin C yokwesekwa kwe-antioxidant kanye ne-tyrosinase inhibition
I-Kojic acid, i-arbutin noma i-glycolic acid ukuze isekele ngisho nethoni nokushintsha kwamaseli
I-PDRN (i-polydeoxyribonucleotide) ukusekela ukulungiswa kwesikhumba kanye nokululama kwesithiyo, okubalulekile esikhumbeni esibucayi noma esilimele i-melasma
I-AOMA I-Tranexamic Acid Skin Whitening Injection ene-PDRN ilandela le ndlela esebenza kaningi. Ihlanganisa i-PDRN, i-tranexamic acid, i-glutathione, i-glycolic acid, i-kojic acid ne-vitamin C ezitsheni ezingu-5 mL zokusetshenziswa ngaphakathi kwesikhumba. Ungakwazi ukuqhathanisa eminye imisebenzi ngokugcwele yethu uhla lomjovo wokwenza mhlophe kwesikhumba.
Ukucatshangelwa Kokuphepha
I-Intradermal TXA inerekhodi elihle lokuphepha ezifundweni ezishicilelwe, kodwa ukusetshenziswa okufanele kusencike emkhiqizweni nakudokotela.
Ubunyumba kanye nokulawulwa kwe-pyrogen akuxoxiswana nganoma yimuphi umjovo. Imikhiqizo eyenziwe kabi iyingozi enkulu emhlabeni wangempela kunesithako esisebenzayo ngokwaso.
Ukusabela kwendawo okufana ne-erythema, ukushiswa, imihuzuko kanye nokuvuvukala kwesikhashana kuyimiphumela emibi evame ukubikwa.
Ingozi yesistimu ixoxwa kakhulu nge-TXA yomlomo, efinyelela amazinga aphezulu kakhulu egazi. Ukuhlola ubungozi bokujiyisa kusewumkhuba omuhle ngaphambi kokujova.
Isimo sokulawula siyahlukahluka ngezwe. Ezimakethe eziningi, izixazululo ze-TXA mesotherapy zithengiswa njengemikhiqizo yezimonyo noma yedivayisi yezokwelapha esikhundleni sezidakamizwa. Imitholampilo kufanele ihlole imithetho yendawo ngaphambi kokusetshenziswa.
Ukuthola Izixazululo Ze-TXA Mesotherapy: Uhlu Lokuhlola Abasabalalisi Nemikhiqizo Yomtholampilo
Isidingo semikhiqizo ye-TXA sinamandla ezimakethe ezinamazinga aphezulu e-melasma, okuhlanganisa i-Southeast Asia, i-Middle East, i-Latin America nezingxenye ze-Europe. Uma uhlela ukungenisa noma ukulebula ngokuyimfihlo ifomula ye-TXA, hlola:
Ukubonakala kwefomula: uhlu olugcwele lwesithako olunokugxila okushiwo, hhayi 'i-TXA complex'.
Amazinga okukhiqiza: ISO 13485 kanye nokukhiqizwa okuthobelana ne-GMP, namarekhodi eqoqo.
Amadokhumenti: isitifiketi sokuhlaziya (i-COA), imibiko yokuhlolwa kwe-sterility kanye ne-endotoxin, nokuzinza nedatha yeshelufu yayo yonke inqwaba.
Izinketho zokupakisha: usayizi webhodlela, ubuningi bebhokisi kanye nokulebula okuhlangabezana nezidingo zokubhalisa zemakethe yakho ohlosiwe.
Ukwenza ngendlela oyifisayo: noma ngabe umenzi angakwazi ukulungisa inhlanganisela esebenzayo, isibonelo i-TXA ene-PDN iqhathaniswa ne-TXA ene-glutathione, ukuze ubeke endaweni yakho.
I-AOMA isekela abasabalalisi nemikhiqizo yasemtholampilo ngokwakhiwa, ukugcwalisa kanye nokupakishwa kwelebula yangasese. Funda kabanzi mayelana yethu ngokwezifiso mesotherapy OEM izixazululo.
FAQ
Ingabe umjovo we-tranexamic acid uyasebenza ekwenzeni isikhumba sibe mhlophe?
I-TXA ichazwa kangcono njengesithako sokulawula umbala kune-ejenti 'emhlophe'. Ucwaningo lwezokwelapha lubonisa ukuthi inganciphisa ukuqina kwe-melasma ngisho nethoni engaphandle, kodwa ayishintshi umbala wesikhumba womuntu wemvelo.
Mangaki amaseshini e-TXA mesotherapy adingekayo ku-melasma?
Izifundo eziningi zibandakanya amaseshini ama-4-8 ahlukaniswe isonto elilodwa kuya kwamane, kuye ngephrothokholi nomkhiqizo. Ukuthuthukiswa okubonakalayo ezifundweni ezishicilelwe kuvele cishe emavikini angu-8-12.
Ingabe i-TXA mesotherapy ingcono kune-oral tranexamic acid?
Bafeza izinhloso ezahlukene. I-Oral TXA umuthi kadokotela onemiphumela yesistimu futhi udinga ukuqondisa kukadokotela. I-Intradermal TXA iletha umthamo omncane wendawo ngqo esilonda. Udokotela wesikhumba angase ahlanganise zombili izimo ezimelana nezifo.
Ingabe i-melasma ingabuya ngemva kokwelashwa kwe-TXA?
Yebo. I-Melasma ayilapheki futhi ibangelwa ukukhanya kwe-UV, ukushisa namahomoni. Ukuvikelwa kwelanga kwansuku zonke kanye nezikhathi zokunakekela kuyadingeka ukugcina imiphumela.
Ingabe i-TXA ingahlanganiswa ne-laser noma ama-peels?
Odokotela abaningi basebenzisa i-TXA eduze nama-peels athambile noma ama-laser angamandla aphansi. Ukwelashwa kufanele kuhlukaniswe ngokufanele futhi kuhlelwe uchwepheshe oqeqeshiwe ukuze kugwenywe ukucasuka kanye nokuphindaphinda kombala.
Izikhombo: Lee JH, Park JG, Lim SH, et al. I-intradermal microinjection yendawo ye-tranexamic acid yokwelashwa kwe-melasma ezigulini zase-Asia: isilingo sokuqala somtholampilo. I-Dermatol Surg. 2006;32(5):626–631. Budamakuntla L, Loganathan E, Suresh DH, et al. Ucwaningo olungahleliwe, oluvulekile, oluqhathaniswayo lwe-tranexamic acid microinjections kanye ne-tranexamic acid ene-microneedling ezigulini ezine-melasma. J Cutan Aesthet Surg. 2013;6(3):139–143.
Lesi sihloko esolwazi lochwepheshe kuphela futhi akusona iseluleko sezokwelapha. Ukwelashwa kufanele kwenziwe ngabasebenzi abaqeqeshiwe ngokuhambisana nemithetho yendawo.
